Cargando…

Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor

Transplant-associated thrombotic microangiopathy (TMA) occurs in a significant percentage of patients after allogeneic stem cell transplantation (allo-SCT) and is associated with significant morbidity and mortality. The aim of the present study was to examine the association of serum angiopoetin-2 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vythoulkas, Dionysios, Lazana, Ioanna, Kroupis, Christos, Gavriilaki, Eleni, Konstantellos, Ioannis, Bousiou, Zoi, Chondropoulos, Spiros, Griniezaki, Marianna, Vardi, Anna, Gkirkas, Konstantinos, Karagiannidou, Aggeliki, Batsis, Ioannis, Stamouli, Maria, Sakellari, Ioanna, Tsirigotis, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138628/ https://www.ncbi.nlm.nih.gov/pubmed/37108124 http://dx.doi.org/10.3390/ijms24086960

Ejemplares similares

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
por: Vythoulkas, Dionysios, et al.
Publicado: (2023)

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
por: Stamouli, Maria, et al.
Publicado: (2021)

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
por: Tsirigotis, Panagiotis, et al.
Publicado: (2021)

Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

P1395: PENTAVALENT-SPECIFIC T-CELLS POST HAPLO-IDENTICAL TRANSPLANTATION FOR THE TREATMENT OF OPPORTUNISTIC INFECTIONS
por: Bousiou, Zoi, et al.
Publicado: (2023)

PB2261: DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT
por: Varelas, Christos, et al.
Publicado: (2023)

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
por: Papalexandri, Apostolia, et al.
Publicado: (2023)

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Thrombocytopenia in COVID-19: pathophysiology matters
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
por: Papadopoulou, Anastasia, et al.
Publicado: (2021)

Pneumomediastinum as a rare complication in an immunosuppressed patient with emphysematous cystitis
por: Tsakaldimis, Georgios, et al.
Publicado: (2022)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
por: Angelopoulou, Maria K., et al.
Publicado: (2017)

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents
por: Gavriilaki, Maria, et al.
Publicado: (2019)

Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?
por: Lazana, Ioanna
Publicado: (2022)

Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand
por: Lazana, Ioanna
Publicado: (2023)

PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
por: Gavriilaki, E., et al.
Publicado: (2022)

Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience
por: Gavriilaki, E., et al.
Publicado: (2023)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

A Novel, Cell-Free Therapy to Enter Our Hearts: The Potential Role of Small EVs in Prevention and Treatment of CVD
por: Lazana, Ioanna, et al.
Publicado: (2022)

Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease
por: Mavrikou, Ioulia, et al.
Publicado: (2023)

Neurologic complications after allogeneic transplantation: a meta‐analysis
por: Gavriilaki, Maria, et al.
Publicado: (2019)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
por: Symeonidis, Argiris, et al.
Publicado: (2022)

Complement in Sickle Cell Disease: Are We Ready for Prime Time?
por: Varelas, Christos, et al.
Publicado: (2021)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
por: Demosthenous, Christos, et al.
Publicado: (2021)

PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS
por: Varelas, Christos, et al.
Publicado: (2023)

P1386: USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN ‘OFF-THE-SHELF’ FCΓ-CR-T CELL PRODUCT FOR THE TREATMENT OF HEMATOLOGICAL AND SOLID TUMOR MALIGNANCIES
por: Lazana, Ioanna, et al.
Publicado: (2023)

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center
por: Varelas, Christos, et al.
Publicado: (2022)

Antimicrobial susceptibility testing and reporting practices of public hospital microbiology laboratories in Greece, 2022: A national observational survey and call for action
por: Karagiannidou, Sofia, et al.
Publicado: (2023)

Metadherin, p50, and p65 Expression in Epithelial Ovarian Neoplasms: An Immunohistochemical Study
por: Giopanou, Ioanna, et al.
Publicado: (2014)

Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active
por: Sakellari, Georgia I., et al.
Publicado: (2021)

The Consequences of Tongue Piercing on Oral and Periodontal Tissues
por: Plastargias, Ioannis, et al.
Publicado: (2014)

Modeling Time Effects in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema – A Mixed Model Analysis of Real-World Data
por: Mylona, Ioanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iff38bia01ua2p5eslf37dgi3k